Projected Income Statement: Strategy Incorporated

Forecast Balance Sheet: Strategy Incorporated

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 - - 2,136 7,154 5,889 6,004 - -
Change - - - 234.93% -17.68% 1.96% - -
Announcement Date 01/02/22 02/02/23 06/02/24 05/02/25 05/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Strategy Incorporated

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 - - 2.938 2.978 8.212 5 6.65 6.9
Change - - - 1.36% 175.76% -39.11% 33% 3.76%
Free Cash Flow (FCF) 1 91.13 0.725 9.774 -56.01 -75.45 -103 3,510 3,571
Change - -99.2% 1,248.14% -673.05% -34.71% -36.51% 3,507.72% 1.75%
Announcement Date 01/02/22 02/02/23 06/02/24 05/02/25 05/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Strategy Incorporated

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 19.89% 17.03% 17.11% 6.86% 7.96% 11.73% 15.56% -
EBIT Margin (%) 9.02% 16.6% -23.18% -399.82% -1,140.82% 698.6% 2,250.81% 7,824.59%
EBT Margin (%) -158.86% -264.88% -25.09% -417.37% -1,157.92% 1,157.81% 1,316.24% 982.3%
Net margin (%) -104.84% -294.39% 86.47% -251.73% -886.26% 3,009.56% 1,062.83% 7,715.47%
FCF margin (%) 17.84% 0.15% 1.97% -12.09% -15.81% -20.54% 681.01% 677.82%
FCF / Net Income (%) -17.02% -0.05% 2.28% 4.8% 1.78% -0.68% 64.08% 8.79%

Profitability

        
ROA - - - - - 14.9% 11.5% 1.6%
ROE - - - - - 27.85% 9.98% 1.7%

Financial Health

        
Leverage (Debt/EBITDA) - - 25.16x 224.84x 155.06x 102.11x - -
Debt / Free cash flow - - 218.52x -127.72x -78.04x -58.29x - -

Capital Intensity

        
CAPEX / Current Assets (%) - - 0.59% 0.64% 1.72% 1% 1.29% 1.31%
CAPEX / EBITDA (%) - - 3.46% 9.36% 21.62% 8.5% 8.29% -
CAPEX / FCF (%) - - 30.06% -5.32% -10.88% -4.85% 0.19% 0.19%

Items per share

        
Cash flow per share 1 - - - - - - - -
Change - - - - - - - -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 - - - - - - - -
Change - - - - - - - -
EPS 1 -5.344 -12.98 2.642 -6.06 -15.23 53.05 14.27 84.78
Change - -142.95% 120.35% -329.37% -151.32% 448.33% -73.11% 494.28%
Nbr of stocks (in thousands) 106,452 113,177 156,369 245,459 302,470 350,940 350,940 350,940
Announcement Date 01/02/22 02/02/23 06/02/24 05/02/25 05/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E ratio 3.36x 12.5x
PBR - -
EV / Sales 137x 121x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
178.03USD
Average target price
380.43USD
Spread / Average Target
+113.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MSTR Stock
  4. Financials Strategy Incorporated